Biological response of human aortic endothelial cells exposed to acellular hemoglobin solutions developed as potential blood substitutes

Life Sciences

Volumn 72, Issue 10, 2003, Pages 1143-1157

  Toussaint Hacquard, Marie ^a,b   Devaux, Y ^b   Longrois, D ^b   Faivre Fiorina, B ^a   Muller, S ^c   Stoltz, J F ^c   Vigneron, C ^a   Menu, P ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c CNRS   (France)

Author keywords

Blood substitute; Cell free hemoglobin; Endothelial cell; ICAM 1; Nitric oxide synthase

Indexed keywords

BLOOD SUBSTITUTE; HEMOGLOBIN BASED OXYGEN CARRIER; HEMOGLOBIN DEXTRAN BENZENE TETRACARBOXYLATE; INTERCELLULAR ADHESION MOLECULE 1; ISOENZYME; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

AORTA; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL FUNCTION; CELL MEMBRANE; CONTROLLED STUDY; DOWN REGULATION; DRUG RESPONSE; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPOTHESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

AORTA; BLOOD SUBSTITUTES; BLOTTING, WESTERN; CHEMISTRY, PHYSICAL; DENSITOMETRY; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE; HEMOGLOBINS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER;

EID: 0037462290     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)02368-8     Document Type: Article

References (44)

1. Abassi Z., Kotob S., Pieruzzi F., Abouassali M., Keiser H., Fratantoni J., Alayash A.I. Effect of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. Journal of Laboratory and Clinical Medicine. 129:1997;603-610.
2. Alayash A.I. Hemoglobin-based blood substitutes and the hazards of blood radicals. Free Radical Research. 33:2000;341-348.
3. Allen R.G., Tresini M. Oxidative stress and gene regulation. Free Radical and Biology and Medicine. 28(3):2000;463-499.
4. Beckman J.S. The physiological and pathological chemistry of nitric oxide. Lancaster J. Nitric Oxide Principles and Actions. 1996;1-82 Academic Press, San Diego.
5. Benesch R.E., Kwong S. The stability of the heme-globin linkage in some normal, mutant, and chemically modified hemoglobins. Journal of Biological Chemistry. 265:1990;14881-14885.
6. Carlos T., Harlan J. Leukocyte-endothelial adhesion molecules. Blood. 84(7):1994;2068-2101.
7. Carmichael F.J., Biro G., Cheng D. Phase III clinical trial of Hemolink™ in conjunction with intraoperative autologous donation (IAD) in cardiac surgical patients. Artificial Cells, Blood Substitutes and Immobilization Biotechnology. 29(2):2001;102.
8. Caron A., Menu P., Faivre-Fiorina B., Labrude P., Alayash A.I., Vigneron C. Systemic and renal hemodynamics after moderate hemodilution with HbOCs in anesthetized rabbits. American Journal of Physiology. 278(6):2000;H1974-H1983.
9. Cines D., Pollak E., Buck C., Loscalzo J., Zimmerman G., Mc Ever R., Pober J., Wick T., Konkle B., Schwartz B., Barnathan E., Mc Crae K., Hug B., Schmidt A.M., Stern D. Endothelial cells in physiology and in the pathophysiology of vascular disorder. Blood. 91(10):1998;3527-3561.
10. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry. 162(1):1987;156-159.
11. Collins T., Read M., Neish A., Withley M., Thanos D., Maniatis T. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine inducible enhancers. FASEB Journal. 9:1995;899-909.
12. Devaux Y., Grosjean S., Seguin C., David C., Dousset B., Zannad F., Meistelman C., De Talance N., Mertes P.M., Ungureanu-Longrois D. Retinoic acid and host-pathogen interactions: effects on inducible nitric oxide synthase in vivo. American Journal of Physiology. 279(5):2000;E1045-E1053.
13. Doherty D.H., Doyle M.P., Curry S.R., Vali R.J., Fattor T.J., Olson J.S., Lemon D.D. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nature Biotechnology. 16:1998;672-676.
14. Faivre B., Menu P., Labrude P., Grandgeorge M., Vigneron C. Methemoglobin formation after administration of hemoglobin conjugated to carboxylate dextran in guinea pigs. Attempt to prevent the oxydation of hemoglobin. Artificial Cells, Blood Substitutes and Immobilization Biotechnology. 22:1994;551-558.
15. Faivre-Fiorina B., Caron A., Fassot C., Fries I., Menu P., Labrude P., Vigneron C. Presence of hemoglobin inside aortic endothelial cells after cell-free hemoglobin administration in guinea pigs. American Journal of Physiology. 276:1999;H766-H770.
16. Förstermann U., Kleinert H. Nitric oxide synthase: expression and expressional control of the three isoforms. Nanunyn-Schmiedeberg's Archives of Pharmacology. 352:1995;351-364.
17. Goldman D.W., Breyer R.J., Yeh D., Brockner-Ryan B.A., Alayash A.I. Acellular hemoglobin-mediated oxidative stress toward endothelium: a role for ferryl iron. American Journal of Physiology. 275:1998;H1046-H1053.
18. Gould S.A., Moore E., Hoyt D., Burch J., Haenel J., Garcia J., DeWoskin R., Moss G. The first randomised trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. Journal of American College of Surgery. 187:1998;113-122.
19. Griffon N., Baudin V., Dieryck W., Dumoulin A., Pagnier J., Poyart C., Marden M.C. Tetramer-dimer equilibrium of oxyhemoglobin mutants determined from auto-oxidation rates. Protein Science. 7:1998;673-680.
20. Gulati A., Barve A., Sen A.P. Pharmacology of hemoglobin therapeutics. Journal of Laboratory and Clinical Medicine. 133:1999;112-119.
21. Huang Z., Fasco M.J., Kaminski L.S. Optimization of DNAse I removal of contaminating DNA from RNA for use in quantitative RNA-PCR. Siebert P. The PCR technique: RT-PCR. 1997;31-37 Eaton Publishing, Palo Alto, CA.
22. Ignarro L.J. Nitric oxide: a unique endogenous signaling molecule in vascular biology. Bioscience Reports. 19(2):1999;51-71.
23. Kim H., Greenburg A. Ferrous hemoglobin scavenging of endothelium-derived nitric oxide is a principal mechanism for hemoglobin-mediated vasoactivities in isolated rat thoracic aorta. Artificial Cells, Blood Substitutes and Immobilization Biotechnology. 25:1997;121-133.
24. Kristiansen M., Graversen J.H., Jacobsen C., Sonne O., Hoffman H.J., Law A. Identification of the haemoglobin scavenger receptor. Nature. 409:2001;198-201.
25. Lamas S., Marsden P., Li K., Tempst P., Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proceedings of the National Academy of Science USA. 89:1992;6348-6352.
26. Lamy M.L., Daily E.K., Brichant F.K., Larbuisson R.P., Demeyere R.H., Vandermeersch E.A., Lehot J.J., Parsloe M.R., Berridge J.C., Sinclair J.C., Baron J.F., Przybelski R.J. Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. Anesthesiology. 92(3):2000;646-656.
27. Laufs U., La Fata V., Plutzky J., Liao J.K. Upregulation of endothelial nitric oxide synthase by HMGCoA reductase inhibitors. Circulation. 97(12):1998;1129-1135.
28. Macdonald V., Vandegriff K., Winslow R.M., Currell D., Fronticelli C., Hsia J., Bakker J.C. Oxidation rates and stability in solution of mono- and bivalently cross-linked human hemoglobin. Artificial Cells, Blood Substitutes and Immobilization Biotechnology. 19:1991;425.
29. Machi T., Kassel N., Tanaka Y., Hudson S., Lehman G., Harrison T. Hemoglobin damages the cultured endothelial cell monolayer from bovine cerebral arteries. Fukuoka Acta Medica. 87(9):1996;189-196.
30. Motterlini R., Foresti R., Vandegriff K., Intaglietta M., Winslow R.M. Oxidative stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. American Journal of Physiology. 38:1995;H648-H655.
31. Munn L., Koenig G., Jain R., Melder R. Kinetics of adhesion molecule expression and spatial organization using targeted sampling fluorometry. Biotechniques. 19(4):1995;622-631.
32. Prouchayret F., Fasan G., Grandgeorge M. A potential blood substitute from carboxylic dextran and oxyhemoglobin. I. Preparation, purification and characterization. Chang T.M.S. Blood Substitutes and Oxygen Carriers. 1993;144-147 Marcel Dekker, New York.
33. Ravichandran L.V., Johns R.A., Rengasamy A. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. American Journal of Physiology. 268(6 Pt 2):1995;H2216-H2223.
34. Rohlfs R.J., Bruner E., Chiu A., Gonzales A., Gonzales M.L., Magde D., Magde M.D., Vandegriff K., Winslow R.M. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. Journal of Biological Chemistry. 273:1998;12128-12134.
35. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning. A laboratory manual. 2nd ed. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
36. Simoni J., Simoni G., Lox C., Prien S., Tran R., Shires T. Expression of adhesion molecules and Von Willebrand factor in human coronary artery endothelial cells incubated with differently modified hemoglobin solutions. Artificial Cells, Blood Substitutes and Immobilization Biotechnology. 25(1-2):1997;211-225.
37. Simoni J., Simoni G., Lox C., Prien S., Shires T. Modified hemoglobin solution with desired pharmacological properties does not activate nuclear transcription factor NF-kappa B in human vascular endothelial cells. Artificial Cells, Blood Substitutes and Immobilization Biotechnology. 25(1-2):1997;193-210.
38. Stowell C., Levin J., Spiess B., Winslow R.M. Progress in the development of RBC substitutes. Transfusion. 41:2001;287-299.
39. Toussaint M., Latger-Cannard V., Caron A., Lecompte T., Stoltz J.F., Vigneron C., Menu P. Effect of three Hemoglobin-Based Oxygen Carrying Solutions on neutrophil activation in vitro: Quantitative measurement of the expression of adherence receptors. Transfusion. 41(2):2001;226-231.
40. Vandegriff K., Le Tellier Y. A comparison of rates of heme exchange: site specifically cross-linked versus polymerized human hemoglobins. Artificial Cells, Blood Substitutes and Immobilization Biotechnology. 22:1994;443-455.
41. Vaziri N., Wang X. cGMP-mediated negative feedback regulation of endothelial nitric oxide synthase expression by nitric oxide. Hypertension. 34:1999;1237-1241.
42. Wagener F., Feldman E., De Witte T., Abraham N. Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E-selectin in vascular endothelial cells. Proceedings of the Society for Experimental Biology and Medicine. 216:1997;456-463.
43. Winslow R.M., Chapmann K.W. Pilot scale preparation of hemoglobin solutions. Everse J., Vandegriff K.D., Winslow R.M. Methods in Enzymology. Hemoglobins, Biochemical and Analytical Methods. vol. 231(part B):1994;3-16 FL Academic, Orlando.
44. Winslow R.M., Gonzales A., Gonzales M.L., Magde M., Mc Carthy M., Rohlfs R.J., Vandegriff K.D. Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model. Journal of Applied Physiology. 85(3):1998;993-1003.